BLMN enters its Q2 earnings release — scheduled for tomorrow morning — with short interest at a multi-month high, analysts uniformly cautious, and options traders edging slightly more defensive ahead of the print.
The most striking positioning story is the rebuild in short interest over the past month. Bears have added meaningfully since early July, with short interest climbing roughly 14% over thirty days to reach 9.6% of the free float. That is not an extreme reading by any measure, but the pace of accumulation is notable — shorts held roughly 7.3 million shares at the start of July and now sit at 8.2 million. The cost to borrow has actually eased during this build, falling about 29% over the week to under 0.5%, which means new short positions remain cheap to put on. Availability is exceptionally loose at over 1,100% — more than eleven shares available to borrow for every one currently lent out — so there is no supply constraint limiting further additions. The ORTEX short score sits at 50, squarely mid-range, suggesting the positioning is notable but not yet extreme enough to screen as a crowded short.
Options tell a slightly different story. The put/call ratio ticked up to 0.53 on Tuesday — above its 20-day average of 0.46 but only about 0.7 standard deviations above it. That is a mild lean toward protection rather than a strong defensive signal. The 52-week high on the PCR is 0.88, so today's reading leaves plenty of room for hedging to intensify. Taken together, the two positioning signals point in the same direction — modest caution rather than outright fear — which makes tomorrow's print the deciding factor for how quickly that can shift.
The Street is almost entirely neutral, with no meaningful bull conviction in sight. Citigroup trimmed its target to $8.75 from $9.50 last week, maintaining a Neutral rating. Goldman Sachs and Barclays both raised targets following the May earnings beat — Goldman to $8.50, Barclays to $9.00 — but neither moved off a neutral stance. JPMorgan sits at Underweight with a $6 target, the lone outlier in the bear direction. The consensus mean price target of roughly $8.70 is fractionally below the current price of $8.92, which is itself a signal: the Street broadly does not see meaningful upside even after the stock's 14% gain since early May. The EPS momentum score ranks in the 20th percentile over 30 days, meaning estimate revisions have been running negative heading into the release.
The most important institutional development is the ownership landscape. BlackRock added over 540,000 shares in the quarter to June, lifting its stake to 7.5% of shares — the largest holder. Activist Starboard Value holds nearly 5%, though it trimmed modestly earlier in the year. Several quantitative firms — AQR, Arrowstreet, Two Sigma — each built new or substantially larger positions through Q1, collectively adding several million shares. That institutional buying provides a floor of sorts, but it also reflects value-oriented and quant-driven interest rather than fundamental conviction about a recovery in traffic.
The earnings history adds the sharpest piece of context. The most recent comparable print — Q1 results in May — saw the stock jump 38% in a single session and extend the move to 44% over five days. That was almost certainly a relief rally after an extended period of negative revisions and depressed expectations. The bear case points to a 10% three-year traffic decline and two substantial guidance cuts in the prior four quarters. The bull case rests on outperformance at Carrabba's and Fleming's and sequential improvement in comparable sales trends. With the stock back near $9 and the Street's targets clustered just below that level, tomorrow's key variable is whether management's tone on traffic and full-year guidance is enough to justify holding the ground gained since May — or whether a second look at the numbers revives the bear thesis.
What to watch: whether Q2 comparable sales at Outback show the same sequential improvement flagged at other brands, and how management frames the second-half outlook given the Street's current EPS estimates sit toward the low end of the prior guidance range.
See the live data behind this article on ORTEX.
Open BLMN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
